About CovalX



CovalX AG was founded in 2005, based on the research work of Dr. Alexis Nazabal and Dr. Ryan Wenzel, postdocs in the laboratory of Professor Renato Zenobi at the Swiss Federal Institute of Technology (ETH) in Zürich. The company's vision is to become a leading provider of technology and services in the field of protein interaction analysis based on mass spectrometry. With support offices in Europe, North America and Japan, CovalX is a global company offering leading product and services for major pharmaceutical companies as well as academic laboratories. CovalX is a fast growing company, developing inovative analysis solutions for the characterization of therapeutic proteins and protein interactions for the life science industry.